Go to deals
Healthcare

Ungstöd Sverige AB has been acquired by Nytida AB

June 2015 — Nytida AB has acquired Ungstöd Sverige AB for US$10 million.

Ungstöd, founded in 2007 and headquartered in Stockholm, is a non-institutional care provider offering services requiring state permits in accordance with the Social Services Act (sv. SoL) and the Act Concerning Support and Service for Persons with Certain Functional Impairments (sv. LSS). Ungstöd is a specialized care provider offering support and care for children with social and psychiatric problems.

Nytida AB is a leading player in the Swedish market offering support and assistance to people with medical and social disabilities. The company, with 250 established operations throughout the country and sales of approximately US$117 million, offers a wide range of non-institutional care services.

“Avantus has supported us throughout the whole process, with great commitment and sector expertise, and has played a pivotal role in what has become an outcome far beyond our expectations”, said Emil Wallgren, co-founder and CEO, Ungstöd.

Our role in the transaction

Oaklins' team in Sweden advised the seller in this transaction.

Parties

Talk to the deal team

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Nikolaos Karabelas

Partner
Stockholm, Sweden
Oaklins Sweden

Related deals

Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more
Life & Mobility has attracted investor Bolster Investment Partners
Private Equity | Healthcare

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Learn more
Synergia and Bolster have secured acquisition financing for Life & Mobility
Private Equity | Healthcare

Synergia and Bolster have secured acquisition financing for Life & Mobility

Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.

Learn more